Bulgaria – Pharmaceutical products – Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health
Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry o
Opportunity description
Contract award notice pursuant to Art. 266a, para. 5, item 3 of the Medicinal Products in Human Medicine Act, in conjunction with Art. 1, para. 1, item 2, Art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health. The Contractor agrees, after receiving a letter of consent from the Bulgarian Drug Agency (BDA) and a written request for delivery of the medicinal product specified below, to deliver the following medicinal product in the quantities prescribed by “UMHAT St. Ivan Rilski” EAD by protocol – Appendix No. 1 (which is applicable), issued pursuant to Ordinance No. 10 / 17.11.2011, according to the CONTRACTOR'S offer. - International non-proprietary name: Ganaxolone, Ztalmy, Almac Pharma Services Limited, Oral suspension, 50mg/ml, 110ml, bottle, number of dosage forms per package 1, quantity of packages -17; Procedure: neg-wo-call. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.